Home / TEAM / Cardiology / Doctor / Yi-Heng, Li
Doctor
 |
|
|---|---|
|
Yi-Heng, Li
Professor, attending physician |
|
|
Department of medicine, Kaohsiung Medical University College of Medicine PhD, the Institute of Basic Medical Sciences, Medical College of National Cheng Kung University |
|
| Cardiovascular disease | |
|
Yi-Heng Li, MD, PhD, is a senior attending physician of the Division of Cardiology at National Cheng Kung University Hospital in Tainan, Taiwan, where he is also a professor and head of the Department of Internal Medicine in the University’s College of Medicine. Dr. Li earned his medical degree from Kaohsiung Medical University in Kaohsiung, Taiwan, and his PhD from the Graduate Institute of Basic Medical Science at National Cheng Kung University. He received cardiology fellowship training in the National Taiwan University Hospital in Taipei, Taiwan and completed a research fellowship in the Department of Cardiovascular Sciences and the Debakey Heart Center at Baylor College of Medicine in Houston, Texas, USA. Dr. Li is a fellow of the European Society of Cardiology (FESC) and the American College of Cardiology (FACC). His research interests include the management of acute coronary syndromes, lipids and atherothrombosis. Dr. Li has published more than 200 research papers in such medical journals as the Journal of the American College of Cardiology, European Heart Journal, Arteriosclerosis, Thrombosis, and Vascular Biology, Cardiovascular Research, Chest, American Journal of Cardiology, and Thrombosis and Haemostasis. He has presented more than 200 abstracts at international meetings, including the Annual Scientific Sessions of the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. He has been the local principal and co-investigator of many international clinical trials. He is the chairman of the writing group for the “2022 Taiwan Lipid Guidelines for Primary Prevention”, “2020 Guidelines of the Taiwan Society of Cardiology for the Management of ST-segment Elevation Myocardial Infarction” and “2017 Taiwan Lipid Guideline for High Risk Patients”. |
|
| Make an appointment | |
| Research NCKU | |
